North Brunswick, NJ and Bristol, PA — NJ Biopharmaceuticals LLC (d/b/a NJ Bio), a CRO providing integrated chemistry and biology services, was awarded Runner Up in the Best Contract Research Provider category at the 7th Annual World ADC Awards.
The Best CRO Provider Award is given to Contract Research Providers in preclinical and clinical research field for their service range, reliability, value, customer satisfaction, and uniqueness in the ADC market.
Dr. Naresh Jain, President & CEO of NJ Bio, thanked his team for their diligent efforts and hard work, and all clients and the judges at the World ADC Awards for their votes to select NJ Bio as the runner up in this category.
Dr. Jain states “winning this prestigious award in just two years since NJ Bio’s inception clearly indicates our commitment to deliver high quality affordable, customizable, and expert solutions for bioconjugations and payload linker synthesis to our clients. NJ Bio looks forward to consistently bringing value to clients’ research programs through our expertise in ADCs and innovative solutions.”
